J&J, Basilea To Base Ceftobiprole Filing For Hospital-Acquired Pneumonia On Phase III Results
This article was originally published in The Pink Sheet Daily
Executive Summary
Despite positive results in patients with hospital-acquired pneumonia, the Phase III study failed to demonstrate non-inferiority in a high-risk subgroup.